库伦-德弗里斯综合征:从诊断到治疗的旅程
Anna C Pfalzer1,2, Blake Ivers3, Alayna Haynam3
1Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Therapeutic advances in rare disease
|July 31, 2024
概括
库伦·德弗里斯综合征基金会促进了库伦·德弗里斯综合征 (KdVS) 的研究和治疗开发. 他们的十年的工作支持了2026年临床试验目标.
科学领域:
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
- 临床研究 临床研究
背景情况:
- 库伦-德弗里斯综合征 (KdVS) 是一种罕见的遗传疾病.
- 库伦·德弗里斯综合症基金会成立于2013年.
- 需要增加KdVS的研究和治疗选择.
研究的目的:
- 概述基金会在推动KdVS研究和患者护理方面的举措.
- 突出发展科学资源和促进国际合作的进展.
- 为启动KdVS的第一个临床试验设定目标.
主要方法:
- 通过患者细胞和动物模型开发科学资源.
- 为基础和临床KdVS研究提供种子资金.
- 建立一个自然历史研究和增加患者的参与.
- 优先考虑国际研究,翻译研究和以患者为中心的研究.
主要成果:
- 在过去的十年中,KdVS研究和患者社区的显著增长.
- 开发科学资源和建立一个自然历史研究.
- 更多地关注国际合作和翻译研究.
结论:
- 该基金会的专注努力为推进KdVS理解和治疗奠定了基础.
- 已建立的社区和研究基础设施支持2026年临床试验的雄心勃勃的目标.
- 持续的国际合作和患者参与对于未来的进步至关重要.
更多相关视频
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
806
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
9.6K
相关概念视频
Cystic Fibrosis: Management
151
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
151
Inborn Errors of Metabolism
150
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
150
Methods of reducing fever
652
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
652
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Renal Tubule and Collecting Duct
886
The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
886
Electroconvulsive Therapy
30
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
30
